ConductScience.org, home

Comparison · NCT05478174-cd78a04f

HSK3486 vs Propofol: Percentage of Subjects With Any Injection-site Pain on Numeric Rating Scale ≥1

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. HSK3486 vs Propofol: Percentage of Subjects With Any Injection-site Pain on Numeric Rating Scale ≥1. Trial comparisons, record NCT05478174-cd78a04f. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05478174-cd78a04f

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1650.1240.215wilson
Risk in group 20.4530.370.539wilson
Risk difference, group 1 minus group 2-0.288-0.384-0.191newcombe hybrid score
Risk ratio, group 1 over group 20.3630.260.508log
Odds ratio, group 1 over group 20.2380.1470.385log
Number needed to treat, for one fewer participant with the outcome on HSK3486 than on Propofol3.472.615.24from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1HSK3486HSK3486 for general anesthesia induction~HSK3486: HSK3486 for induction of general anesthesia42255OG000
Group 2PropofolPropofol for general anesthesia induction~Propofol: Propofol for induction of general anesthesia.58128OG001

Outcome

Type
SECONDARY
Title
Percentage of Subjects With Any Injection-site Pain on Numeric Rating Scale ≥1
Description
0 = No Pain 1-3 = Mild Pain 4-6 = Moderate Pain 7-9 = Severe Pain 10 = Worst pain imaginable
Time frame
From start of drug administration to MOAA/S ≤1 (up to 3 minutes)
Population

Source ClinicalTrials.gov

Trial

Title
Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia
NCT number
NCT05478174
Phases
PHASE3
Conditions
General Anesthesia
Interventions
HSK3486, Propofol
Lead sponsor
Haisco-USA Pharmaceuticals, Inc.
Results first posted
2024-10-29

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT05478174-cd78a04f